Recent Options Activity for Exact Sciences Corporation
Recently, investors have shown a strong interest in Exact Sciences (NASDAQ: EXAS). This uptick in options activity is crucial for retail traders to grasp, as significant changes in stock options often reflect shifts in how the market feels about a stock.
As we keep an eye on the evolving trends, we've noticed a notable spike in larger trades detailed in today's public options history. These trades could be linked to either institutional investors or individual traders with considerable capital. Still, the overall volume of trading suggests that someone expects a major shift is about to happen with Exact Sciences.
Earlier today, our options scanner highlighted nine distinct trades focused on Exact Sciences. This volume is noticeably above average and certainly warrants attention.
Examining Market Sentiment
A closer look at the activity indicates that the sentiment among these larger investors is somewhat mixed. Approximately 44% are taking a bullish stand, while 33% are leaning toward bearish positions. Of the trades we've analyzed, there was one put option worth $117,000, compared to eight calls totaling around $372,081.
Projected Price Movements for Exact Sciences
Our assessment of the volume and open interest related to these options suggests that large investors are predicting the price of Exact Sciences will likely fluctuate between $55.0 and $85.0. This expectation aligns with the activity we've seen over the past quarter.
Insights on Trade Volume and Open Interest
The trading landscape today showed that the average open interest for Exact Sciences options hovers around 1,016.57, paired with a total volume of 2,211.00. This information helps us gauge which way the market sentiment might be headed in the near future.
Understanding Recent Options Trades
To provide more clarity on recent trades, here's a summary of the significant options activity we've observed in the past month:
- Symbol: EXAS
- PUT/CALL: PUT
- Trade Type: TRADE
- Sentiment: BULLISH
- Expiration Date: 11/15/24
- Price: $4.3
- Total Trade Price: $117,000
- Volume: 300
- Open Interest: 10
- Symbol: EXAS
- PUT/CALL: CALL
- Trade Type: SWEEP
- Sentiment: BEARISH
- Expiration Date: 09/20/24
- Price: $3.0
- Total Trade Price: $59,000
- Volume: 1.1K
- Open Interest: 4.1K
All About Exact Sciences
Exact Sciences is well-known in the healthcare field for its innovative cancer screening and diagnostic testing solutions. The company's flagship product, Cologuard, is a noninvasive stool-based DNA test designed for colorectal cancer screening. Additionally, Exact Sciences is involved in precision oncology through Oncotype DX, which provides genomic tests predicting cancer recurrence risks for breast and colon cancer, alongside OncoExTra, a liquid biopsy assessment for in-depth genomic profiling.
Current Market Status of Exact Sciences
- Recent trading volumes for Exact Sciences have reached about 3,695,220 shares, with the stock price experiencing a rise of 1.8%, bringing it to $66.72.
- The Relative Strength Index (RSI) indicates that EXAS may be approaching overbought conditions.
- Investors should be aware that the next earnings report is anticipated in roughly 44 days.
Analyst Opinions on Exact Sciences
In the past month, three analysts shared their perspectives on EXAS, arriving at an average target price of approximately $78.33. Here’s a quick summary of their evaluations:
- A Wells Fargo analyst downgraded their outlook to Overweight with a target of $75.
- Canaccord Genuity has maintained a Buy rating, also targeting $75.
- Piper Sandler continues with an Overweight rating, setting their target at $85.
While trading options carries more risks compared to direct stock trading, they also open doors to potentially higher returns. Savvy options traders reduce risks through ongoing education, smart entry and exit strategies, and by keeping an eye on various market indicators.
Frequently Asked Questions
What is Exact Sciences Corporation known for?
Exact Sciences specializes in cancer screening and diagnostic tests, including the well-known Cologuard test for colorectal cancer screening.
What does recent options activity indicate about Exact Sciences?
Increased options activity often signifies potential market movement or anticipations, suggesting traders have insights into future developments for the company.
What was the recent stock trading volume for EXAS?
The recent trading volume for Exact Sciences was approximately 3,695,220 shares, indicating active trading and interest in the stock.
Who are the key analysts covering Exact Sciences?
The analysts from firms such as Wells Fargo, Canaccord Genuity, and Piper Sandler are among those providing insights and ratings for Exact Sciences.
Where can I find real-time options updates for Exact Sciences?
Real-time updates on options trades for Exact Sciences can be accessed through financial news services, trading platforms, and relevant market analysis tools.
